Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Molecules ; 24(17)2019 Aug 26.
Article in English | MEDLINE | ID: mdl-31454974

ABSTRACT

Piper cubeba L. is the berry of a shrub that is indigenous to Java, Southern Borneo, Sumatra, and other islands in the Indian Ocean. The plant is usually used in folk traditional medicine and is an important ingredient in cooking. The purpose of this study was to isolate and purify the bioactive compounds from P. cubeba L. fractions. In addition, the isolated compounds were tested for their antibacterial and antispore activities against vegetative cells and spores of Bacillus cereus ATCC33019, B. subtilis ATCC6633, B. pumilus ATCC14884, and B. megaterium ATCC14581. The phytochemical investigation of the DCM fraction yielded two known compounds: ß-asarone (1), and asaronaldehyde (2) were successfully isolated and identified from the methanol extract and its fractions of P. cubeba L. Results showed that exposing the vegetative cells of Bacillus sp. to isolated compounds resulted in an inhibition zone with a large diameter ranging between 7.21 to 9.61 mm. The range of the minimum inhibitory concentration (MIC) was between 63.0 to 125.0 µg/mL and had minimum bactericidal concentration (MBC) at 250.0 to 500.0 µg/mL against Bacillus sp. Isolated compounds at a concentration of 0.05% inactivated more than 3-Log10 (90.99%) of the spores of Bacillus sp. after an incubation period of four hours, and all the spores were killed at a concentration of 0.1%. The structures were recognizably elucidated based on 1D and 2D-NMR analyses (1H, 13C, COSY, HSQC, and HMBC) and mass spectrometry data. Compounds 1, and 2 were isolated for the first time from this plant. In conclusion, the two compounds show a promising potential of antibacterial and sporicidal activities against Bacillus sp. and thus can be developed as an anti-Bacillus agent.


Subject(s)
Aldehydes/pharmacology , Anisoles/pharmacology , Anti-Bacterial Agents/pharmacology , Piper/chemistry , Spores, Bacterial/drug effects , Aldehydes/isolation & purification , Allylbenzene Derivatives , Anisoles/isolation & purification , Anti-Bacterial Agents/isolation & purification , Bacillus cereus/drug effects , Bacillus cereus/physiology , Bacillus megaterium/chemistry , Bacillus megaterium/drug effects , Bacillus pumilus/drug effects , Bacillus pumilus/physiology , Bacillus subtilis/drug effects , Bacillus subtilis/physiology , Chromatography, Thin Layer , Medicine, Traditional , Microbial Sensitivity Tests , Molecular Structure , Plant Extracts/isolation & purification , Plant Extracts/pharmacology
2.
Med Chem ; 9(8): 1091-8, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23092331

ABSTRACT

A series of novel isoxazole and pyrazoline derivatives has been synthesized and evaluated for their effects on the chemiluminescence and chemotactic activity of human phagocytes. Their effects on the chemotactic migration of isolated polymorphonuclear leukocytes (PMNs) and on the release of reactive oxygen species (ROS) during respiratory burst of human whole blood and PMNs were carried out using the Boyden chamber technique and luminol-based chemiluminescence assay, respectively. Of the compounds tested, compounds 8, 9, 11 and 12 exhibited higher inhibitory activity on the release of ROS (with IC50 values ranging from 5.6 to 8.4 µM) than acetylsalicylic acid (IC50 = 9.5 µ M). These compounds also showed strong inhibitory activity on the migration of PMNs with compound 8 exhibiting an IC50 value lower than that of ibuprofen. The results suggest that some of these isoxazole and pyrazoline derivatives have ability to modulate the innate immune response of phagocytes at different steps, indicating their potential as a source of new immunomodulatory agents.


Subject(s)
Chemotaxis/drug effects , Isoxazoles/pharmacology , Neutrophils/drug effects , Phagocytes/drug effects , Pyrazoles/pharmacology , Reactive Oxygen Species/metabolism , Zymosan/pharmacology , Cell Survival/drug effects , Dose-Response Relationship, Drug , Humans , Isoxazoles/chemical synthesis , Isoxazoles/chemistry , Luminescence , Molecular Structure , Neutrophils/metabolism , Phagocytes/cytology , Phagocytes/metabolism , Phagocytosis/drug effects , Pyrazoles/chemical synthesis , Pyrazoles/chemistry , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...